SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
---------
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
LION BIOSCIENCE AKTIENGESELLSCHAFT
(Exact Name of Registrant as Specified in its Charter)
FEDERAL REPUBLIC OF GERMANY
(Jurisdiction of Incorporation or Organization)
Im Neuenheimer Feld 515-517
D-69120 Heidelberg
Germany
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or
will file annual reports under cover of
Form 20-F or Form 40-F.
Form 20-F X Form 40-F
---------
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
--- ---
If "Yes" is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): Not Applicable
Page 1 of 3
LION bioscience Aktiengesellschaft's publication on its corporate web site
concerning a stock trade of a member of Lion's management board as submitted to
the Federal Agency of Financial Services in Germany is attached as Exhibit 99
and incorporated by reference in this Form 6-K.
This Report of Foreign Private Issuer on Form 6-K is specifically
incorporated by reference in the Company's Registration Statement of Form F-3
(Reg. No. 333-90730) filed on June 18, 2002, as amended on July 16, 2002.
Exhibit No. Description
99 PUBLICATION ON CORPORATE WEB SITE OF LION BIOSCIENCE AG
Page 2 of 3
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
LION bioscience Aktiengesellschaft
By: /s/ Friedrich von Bohlen und Halbach
------------------------------------
Name: Dr. Friedrich von Bohlen und Halbach
Title: Chief Executive Officer
Dated: December 20, 2002
Page 3 of 3